Marijuana

Marijuana, Inc. (now operating as NexTel Medical Corp. and formerly as Exousia Pro, Inc.) is a clinical-stage biotechnology company specializing in exosome-based therapeutics and diagnostics. The company utilizes a proprietary platform to manufacture plant-based and mammalian exosomes designed for the targeted delivery of nucleic acids, such as DNA and mRNA, and small molecule payloads. Its primary clinical focus is in oncology, with lead programs targeting cancer stem cells in glioblastoma and pancreatic cancer. Additionally, the company has commercialized the NANOG DNA cancer screening test for early detection and is developing exosome-based applications for dermatology and dentistry. Following a series of strategic acquisitions and name changes, the company has transitioned from its cannabis-related origins to a pure-play biotechnology firm focused on precision medicine and drug delivery.